CABA · Cabaletta Bio, Inc. · Held by Funds
The latest filing states the doubt was alleviated.
“As disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, we had previously identified conditions that raised substantial doubt about our ability to continue as a going concern. During the quarter ended September 30, 2026, we raised additional funds through the exercise of common stock warrants for proceeds of $115.0 million and sold 1.9 million shares pursuant to the 2025 ATM Program for net proceeds of $6.0 million. As a result of these cash raises, the conditions that previously raised substantial doubt are no longer present.”View the 10-Q filed Nov 5, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of CABA by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 9.38% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 1.10% | 2,362,239 |
| Index ETFs | 8.28% | 17,863,032 |
| Active ETFs | 0.19% | 408,569 |
| Active funds | 10.81% | 23,327,433 |
| Unclassified | 0.04% | 87,145 |
| All registered funds | 20.42% | 44,048,418 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding CABA
155 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Value Fund, Inc. | — | 7,865,614 | $24,462,060 | 0.23% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 5,256,225 | $16,346,860 | 0.15% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 5,215,188 | $16,219,235 | 0.00% | Long | 2026-06-30 | |
| PGIM Jennison Health Sciences Fund | — | 4,960,717 | $15,427,830 | 1.03% | Long | 2026-08-31 | |
| iShares Russell 2000 ETF | IWM | 2,926,762 | $9,102,230 | 0.01% | Long | 2026-06-30 | |
| PGIM Jennison Small Company Fund | — | 2,696,273 | $8,385,409 | 0.24% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,878,039 | $5,840,701 | 0.01% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,795,663 | $5,584,512 | 0.05% | Long | 2026-06-30 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 1,387,457 | $4,314,991 | 0.05% | Long | 2026-06-30 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,369,957 | $4,260,566 | 0.03% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 1,229,372 | $3,294,717 | 0.01% | Long | 2026-07-31 | |
| iShares Biotechnology ETF | IBB | 1,007,313 | $3,132,743 | 0.03% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 817,761 | $2,543,237 | 0.01% | Long | 2026-08-31 | |
| Franklin Biotechnology Discovery Fund | — | 876,846 | $2,349,947 | 0.20% | Long | 2026-07-31 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | TRSSX | 746,576 | $2,321,851 | 0.05% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 645,788 | $2,008,401 | 0.01% | Long | 2026-08-31 | |
| iShares Russell 2000 Value ETF | IWN | 523,569 | $1,628,300 | 0.01% | Long | 2026-06-30 | |
| iShares Russell 2000 Growth ETF | IWO | 486,921 | $1,514,324 | 0.01% | Long | 2026-06-30 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VFMO | 485,055 | $1,508,521 | 0.08% | Long | 2026-08-31 | |
| Small Cap Value Portfolio | — | 485,013 | $1,508,390 | 0.23% | Long | 2026-06-30 | |
| Nuveen Equity Index Fund | — | 496,689 | $1,331,127 | 0.00% | Long | 2026-07-31 | |
| VANGUARD EXPLORER FUND | — | 448,514 | $1,202,018 | 0.01% | Long | 2026-07-31 | |
| iShares Micro-Cap ETF | IWC | 373,752 | $1,162,369 | 0.08% | Long | 2026-06-30 | |
| PGIM Jennison Blend Fund | — | 361,863 | $1,125,394 | 0.10% | Long | 2026-08-31 | |
| Fidelity Total Market Index Fund | FSKAX | 300,184 | $933,572 | 0.00% | Long | 2026-08-31 | |
| Dimensional U.S. Small Cap ETF | DFAS | 334,526 | $896,530 | 0.01% | Long | 2026-07-31 | |
| Goldman Sachs Small Cap Equity Insights Fund | — | 303,059 | $812,198 | 0.08% | Long | 2026-07-31 | |
| U.S. SMALL CAP PORTFOLIO | DFSTX | 301,437 | $807,851 | 0.00% | Long | 2026-07-31 | |
| Franklin Alternative Strategies Fund | — | 257,027 | $799,354 | 0.14% | Long | 2026-08-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 251,097 | $780,912 | 0.00% | Long | 2026-08-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 250,987 | $780,570 | 0.00% | Long | 2026-08-31 | |
| Schwab Small-Cap Index Fund | SWSSX | 274,359 | $735,282 | 0.01% | Long | 2026-07-31 | |
| Master Small Cap Index Series | — | 210,446 | $654,487 | 0.01% | Long | 2026-06-30 | |
| SMALL COMPANY GROWTH PORTFOLIO | — | 202,673 | $630,313 | 0.04% | Long | 2026-06-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | LABU | 178,606 | $478,664 | 0.10% | Long | 2026-07-31 | |
| Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 172,727 | $462,908 | 0.02% | Long | 2026-07-31 | |
| Ultra-Small Company Fund | BRUSX | 131,497 | $408,956 | 0.41% | Long | 2026-06-30 | |
| Nuveen Small Cap Blend Index Fund | — | 149,656 | $401,078 | 0.01% | Long | 2026-07-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 122,955 | $382,390 | 0.01% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | BRSIX | 122,675 | $381,519 | 0.26% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Portfolio | — | 110,667 | $344,174 | 0.05% | Long | 2026-06-30 | |
| Small Company Value Trust | — | 108,215 | $336,549 | 0.22% | Long | 2026-06-30 | |
| Goldman Sachs Small Cap Value Insights Fund | — | 115,487 | $309,505 | 0.02% | Long | 2026-07-31 | |
| Schwab Total Stock Market Index Fund | SWTSX | 113,690 | $304,689 | 0.00% | Long | 2026-07-31 | |
| Virtus Biotech Clinical Trials Etf | BBC | 103,259 | $276,734 | 0.60% | Long | 2026-07-31 | |
| Fidelity ZERO Total Market Index Fund | FZROX | 93,819 | $251,435 | 0.00% | Long | 2026-07-31 | |
| Fidelity Small Cap Value Index Fund | FISVX | 77,990 | $242,549 | 0.01% | Long | 2026-06-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 76,892 | $239,134 | 0.00% | Long | 2026-06-30 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 69,688 | $216,730 | 0.00% | Long | 2026-08-31 | |
| U.S. MICRO CAP PORTFOLIO | DFSCX | 80,701 | $216,279 | 0.00% | Long | 2026-07-31 |